Howard Goldstein has become senior vice president of sales and marketing, a newly created position, at Seattle-based Amnis. Most recently, he was senior vice president for sales, service, and marketing at Argonaut Technologies. In the past, he held sales and marketing positions at Incyte Genomics, Molecular Devices, Molecular Dynamics, and Applied Biosystems. Goldstein received an MBA from Temple University, an MS in biochemistry from the University of Dayton, and a BS in biology from Bucknell University.
Ian Sanders has become assistant vice president for European life-science sales at Bruker Daltonics. He will also join Bruker Daltonics’ global management team. Sanders has held various positions at Bruker since 2000. He holds a PhD in drug discovery technology from the University of Bath in the UK.
Mark Molloy has become director of biomedical proteomics at the Australian Proteome Analysis Facility at Macquarie University in Sydney, Australia, APAF said this week (see story, p. 1). He returns to APAF from Pfizer in Ann Arbor, Mich., where he was a senior principal scientist. Molloy received a PhD and a BSc in biological sciences from Macquarie.
Harald zur Hausen has joined the scientific advisory board of the German Resource Center for Genome Research (RZPD) in Berlin. Until last year, when he retired from his post, he was the scientific chairman of the German Cancer Research Center in Heidelberg. RZPD recently added antibody arrays to its list of services.
Amit Kumar has joined the board of directors of Research Triangle Park, NC-based Incara Pharmaceuticals. He is the president and CEO as well as a director of CombiMatrix. Kumar received a PhD from the California Institute of Technology and a bachelor’s degree in chemistry from Occidental College in Los Angeles.